TNF-alpha-induced regulation and signalling in macrophages. 1996

D W Riches, and E D Chan, and B W Winston
Department of Pediatrics, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO, USA.

Tumor necrosis factor alpha (TNF-alpha) is a pleiotropic cytokine produced predominantly by macrophages. In addition, macrophages respond to TNF-alpha by differentiating to express different groups of gene products. Our laboratory recently showed that the context in which TNF-alpha is recognized by macrophages dramatically impacts the pattern of gene expression and hence investigating the mechanism of TNF-alpha signal transduction will be important in understanding how this molecule regulates macrophage differentiation. TNF-alpha is recognized by two cell surface receptors, CD120a (p55) and CD120b (p75) that belong to the TNF/NGF receptor family. Signalling is initiated by receptor multimerization in the plane of the plasma membrane. The initial signalling events activated by receptor cross-linking are unknown although activation of the mitogen-activated protein kinase (MAPK) cascade occurs shortly after ligand binding to CD120a (p55). We have investigated the upstream kinases that mediate the activation of p42mapk/erk2 following cross-linking of CD120a (p55) in mouse macrophages. Exposure of mouse macrophages to TNF-alpha stimulated a time-dependent increase in the activity of MEK1, that temporally preceded peak activation of p42mapk/erk2. MEKs, dual specificity T/Y kinases, act as a convergence point for several signalling pathways including Ras/Raf, MEKK and Mos. Incubation of macrophages with TNF-alpha was found to transiently stimulate an MEKK that peaked in activity within 30 sec of exposure and progressively declined towards basal levels by 5 min. By contrast, under these conditions, activation of either c-Raf-1 or Raf-B was not detected. These data suggest that the activation of the MAPK cascade in response to TNF-alpha is mediated by the sequential activation of an MEKK and MEK1 in a c-Raf-1 and Raf-B-independent fashion. The implications of these findings will be discussed in the context of the regulation of macrophage gene expression.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

D W Riches, and E D Chan, and B W Winston
July 2006, European journal of pharmacology,
D W Riches, and E D Chan, and B W Winston
March 2013, Biochimica et biophysica acta,
D W Riches, and E D Chan, and B W Winston
May 1998, Journal of immunology (Baltimore, Md. : 1950),
D W Riches, and E D Chan, and B W Winston
March 2007, Journal of immunology (Baltimore, Md. : 1950),
D W Riches, and E D Chan, and B W Winston
December 2002, Expert reviews in molecular medicine,
D W Riches, and E D Chan, and B W Winston
June 2008, Journal of leukocyte biology,
D W Riches, and E D Chan, and B W Winston
April 2008, Experimental cell research,
D W Riches, and E D Chan, and B W Winston
August 2000, Cytokine,
D W Riches, and E D Chan, and B W Winston
January 2005, In vivo (Athens, Greece),
D W Riches, and E D Chan, and B W Winston
April 1998, The Journal of investigative dermatology,
Copied contents to your clipboard!